iBio (IBIO) Change in Acquisitions & Divestments (2021 - 2023)
iBio's (IBIO) quarterly Change in Acquisitions & Divestments came in at $5.9 million in Q1 2023, up 207.75% year-on-year from $1.9 million in Q1 2022, and up 249.5% on a QoQ basis from $1.7 million in Q4 2022.
iBio (IBIO) Change in Acquisitions & Divestments (2021 - 2023) Analysis & Trends
iBio (IBIO) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $5.9 million in Q1 2023.
- On a quarterly basis, Change in Acquisitions & Divestments rose 207.75% year-over-year to $5.9 million in Q1 2023; TTM through Jun 2023 was $10.8 million, a 20.42% decrease from a year earlier, with the FY2023 full-year figure at $6.7 million, down 50.51% from the prior year.
- Change in Acquisitions & Divestments for Q1 2023 stood at $5.9 million, up from $1.7 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for IBIO reached as high as $13.6 million in Q2 2022 and fell as low as -$5.5 million in Q1 2022.
- Historically, Change in Acquisitions & Divestments has averaged $3.2 million across 3 years, with a median of $2.5 million in 2021.
- On a YoY basis, Change in Acquisitions & Divestments climbed as much as 444.72% in 2022 and fell as far as 467.4% in 2022.
- Year by year, Change in Acquisitions & Divestments stood at $3.1 million in 2021, then slumped by 45.39% to $1.7 million in 2022, then jumped by 249.5% to $5.9 million in 2023.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $5.9 million in Q1 2023, $1.7 million in Q4 2022, and $3.2 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,538.84 Bn | 65,538.56 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 469.46 Bn | 464.67 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.69 Bn | 115.45 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.41 Bn | 61.65 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.84 Bn | 62.84 Bn | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | iBio | 163.85 Mn | 163.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 5.94 Mn |
| Mar 31, 2023 | 5.94 Mn |
| Dec 31, 2022 | 1.70 Mn |
| Dec 31, 2022 | 1.70 Mn |
| Sep 30, 2022 | 3.20 Mn |
| Sep 30, 2022 | 3.20 Mn |
| Jun 30, 2022 | 13.62 Mn |
| Jun 30, 2022 | 13.62 Mn |
| Mar 31, 2022 | -5.51 Mn |
| Mar 31, 2022 | -5.51 Mn |
| Dec 31, 2021 | 3.11 Mn |
| Dec 31, 2021 | 3.11 Mn |
| Sep 30, 2021 | 2.40 Mn |
| Sep 30, 2021 | 2.40 Mn |
| Jun 30, 2021 | 2.50 Mn |
| Jun 30, 2021 | 2.50 Mn |
| Mar 31, 2021 | 1.50 Mn |
| Mar 31, 2021 | 1.50 Mn |